Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_assertion type Assertion NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_head.
- NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_assertion description "[Using an NGS 25-gene panel, the frequency of mutations in genes other than BRCA1/2 was 4.3%, and most mutations (3.9%) were identified in genes associated with breast/ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_provenance.
- NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_assertion evidence source_evidence_literature NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_provenance.
- NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_assertion SIO_000772 25186627 NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_provenance.
- NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_assertion wasDerivedFrom befree-2016 NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_provenance.
- NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_assertion wasGeneratedBy ECO_0000203 NP1216600.RApplHXjaNdphl30tJK4n-ZL91HAx_pZF9foSpox20MA4130_provenance.